Gilles Samyn
Description
Gilles Samyn is an accomplished business leader and experienced board member. He is a director of EyeD Pharma since 2018.
Investor Profile
Gilles Samyn has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series Unknown rounds (top funding stages).
- Majority of deals are located in Belgium.
- Strong thematic focus on Biopharma, Biotechnology, Pharmaceutical.
Stage Focus
- Series Unknown (100%)
Country Focus
- Belgium (100%)
Industry Focus
- Biopharma
- Biotechnology
- Pharmaceutical
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
